HelpAcademyLoginJoin us as a Member

Competitive landscape

Drugs aimed at the same indication, from approved to preclinical.

2 drugs for “Colorectal Neoplasms”

Approved 1

Phase 3 1

  • TAS-102Merck & Co., Inc.Colorectal Neoplasms

Drugs whose recorded indications name this term, by development stage. Indications come from registries and labels, so a drug can appear under related terms.